State of oncology pharmacotherapy.

摘要

The past 40 years have seen the birth and maturation of clinical pharmacy practice across various disciplines. When Drug Intelligence was first launched, clinical pharmacy was much more conceptual than an actual practice. At that time, the field of oncology was also in relative infancy. During the 1960s, there were few well-developed treatment protocols for specific cancers, a lack of effective chemotherapeutic agents, as well as little recognition of true multidisciplinary care. In fact, the first edition of what is considered the "bible" for cancer treatment was not published until 1982. Oncology research was also in its very early stages during this time, and federal regulations governing the conduct of clinical research were not even put into practice until the 1980s. Clinical research has now yielded major advances in the outcome of many oncology patients, particularly in the pediatric arena, and clinical pharmacy oncology practitioners have contributed to many of these research advances.